Pooled multicenter analysis of cardiovascular safety and population pharmacokinetic properties of piperaquine in African patients with uncomplicated falciparum Malaria
Dihydroartemisinin-piperaquine has shown excellent efficacy and tolerability in malaria treatment. However, concerns have been raised of potentially harmful cardiotoxic effects associated with piperaquine. The population pharmacokinetics and cardiac effects of piperaquine were evaluated in 1,000 pat...
Principais autores: | Wattanakul, T, Ogutu, B, Kabanywanyi, AM, Asante, K-P, Oduro, A, Adjei, A, Sie, A, Sevene, E, Macete, E, Compaore, G, Valea, I, Osei, I, Winterberg, M, Gyapong, M, Adjuik, M, Abdulla, S, Owusu-Agyei, S, White, NJ, Day, NPJ, Tinto, H, Baiden, R, Binka, F, Tarning, J |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
American Society for Microbiology
2020
|
Registros relacionados
-
Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with Electrocardiograms.
por: Abdunoor M Kabanywanyi, et al.
Publicado em: (2016-01-01) -
Post-licensure safety evaluation of dihydroartemisinin piperaquine in the three major ecological zones across Ghana.
por: Abraham R Oduro, et al.
Publicado em: (2017-01-01) -
Adherence to Dihydroartemisinin-Piperaquine Treatment among Patients with Uncomplicated Malaria in Northern Ghana
por: Abraham Rexford Oduro, et al.
Publicado em: (2019-01-01) -
Population pharmacokinetics of amodiaquine and piperaquine in African pregnant women with uncomplicated Plasmodium falciparum infections
por: Junjie Ding, et al.
Publicado em: (2024-11-01) -
Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
por: Issaka Zongo, et al.
Publicado em: (2014-01-01)